Wealth Enhancement Advisory Services LLC trimmed its holdings in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 6.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 300,913 shares of the semiconductor company’s stock after selling 20,578 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Lam Research were worth $42,233,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently modified their holdings of LRCX. IMG Wealth Management Inc. bought a new position in shares of Lam Research in the second quarter worth approximately $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research in the 2nd quarter worth $27,000. Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research during the 2nd quarter valued at $29,000. Delos Wealth Advisors LLC bought a new stake in shares of Lam Research during the 2nd quarter worth $30,000. Finally, REAP Financial Group LLC purchased a new position in Lam Research in the second quarter worth $31,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.
Lam Research Stock Performance
NASDAQ LRCX opened at $224.06 on Wednesday. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $229.57. The business has a 50-day moving average price of $174.00 and a 200-day moving average price of $139.28. The firm has a market cap of $281.42 billion, a price-to-earnings ratio of 49.35, a price-to-earnings-growth ratio of 2.55 and a beta of 1.77.
Lam Research Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd were given a dividend of $0.26 per share. The ex-dividend date was Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. Lam Research’s dividend payout ratio is currently 22.91%.
Analysts Set New Price Targets
LRCX has been the topic of several recent research reports. Barclays set a $195.00 price objective on Lam Research in a research report on Thursday, January 15th. Wells Fargo & Company set a $250.00 price objective on shares of Lam Research and gave the company an “overweight” rating in a report on Thursday, January 15th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $265.00 target price (up previously from $210.00) on shares of Lam Research in a research report on Thursday, January 8th. Susquehanna restated a “positive” rating and issued a $250.00 price target on shares of Lam Research in a research note on Monday, January 12th. Finally, Rothschild & Co Redburn upped their price objective on Lam Research from $150.00 to $225.00 and gave the company a “buy” rating in a research report on Tuesday, January 13th. Twenty-eight analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $196.33.
Check Out Our Latest Stock Analysis on LRCX
Insider Activity at Lam Research
In other news, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Bethany Mayer sold 1,298 shares of the business’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the sale, the director owned 1,652 shares in the company, valued at $264,303.48. This represents a 44.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 50,418 shares of company stock valued at $7,667,305. Corporate insiders own 0.31% of the company’s stock.
Lam Research Company Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
See Also
- Five stocks we like better than Lam Research
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
